Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study.

Melissa HobbsRashmi PatelPaul D MorrisonNicola J Kalk James M Stone

Published in: Journal of psychopharmacology (Oxford, England) (2020)

SC use may lead to an increase in the number of days spent in hospital in patients with psychiatric illness. This highlights the need for clinicians to ask specifically about SC use.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
prognostic factors
emergency department
patient reported outcomes
adverse drug
acute care